The ERS and WHO will now provide scientifically sound and evidence-based advice, and clinical consultation through the Internet to national consiliums and individual practitioners on the management of MDR-TB and other difficult-to-treat TB cases, including TB/HIV and paediatric cases.

Making new TB vaccines available to the world over the next 10-15 years is estimated to cost approximately €600 million, utilizing a highly efficient portfolio approach and adequate funding.

The National Institute of Medical Research (NIMR) Muhimbili Research Centre is embarking on a plan to make 'electronic noses' using computer chips to detect TB compounds using breathalysers.

At a university laboratory in Tanzania, an unusual kind of medical research is taking place. Men in white coats watch as rats scurry around glass cages, but these rodents are not test subjects in the latest drug trial. In fact, they're the ones doing the testing, and they're proving rather good at it.

When hijacking a garbage truck, one might as well make use of the trash. That logic drives how tuberculosis-causing bacteria feed, say Cornell scientists.

10 June 2013 - Geneva - The Stop TB Partnership has appointed five new Coordinating Board members who will act as constituency representatives.

The European Union and the Bill & Melinda Gates Foundation today (10 June) pledged to pool resources for research into HIV/Aids, tuberculosis, malaria and other poverty-related diseases.

Click the below NPR broadcast link to hear a story about Moldova.

The U.S., India and other nations are facing shortages of tuberculosis drugs - threatening to reverse decades of progress against a deadly disease that is becoming increasingly untreatable.

Dr Patrick Dakum is the chief executive officer of the Institute of Human Virology in Nigeria. In this interview, he speaks on the prevalence of MDR TB and the institute's efforts to curb and prevent its spread.